Nutraceuticals in joint health: animal models as instrumental tools

Elsa Mével1, Laurent-Emmanuel Monfoulet2, Christophe Merceron3

  • 1INSERM, UMR 791, Skeletal Tissue Engineering and Physiopathology team LIOAD, Nantes, France; Union Grap'Sud, Cruviers-Lascours, France; Université de Nantes, UFR Odontologie, Nantes, France.

Drug Discovery Today
|June 24, 2014
PubMed

Insights

Nutraceuticals show promise in slowing osteoarthritis (OA). This review discusses various animal models used to evaluate nutraceuticals for joint health, aiding researchers in selecting appropriate models for osteoarthritis studies.

Area of Science:

  • Biomedical Science
  • Pharmacology
  • Nutraceutical Research

Background:

  • Osteoarthritis (OA) is a prevalent degenerative joint disease lacking definitive cures.
  • Nutraceuticals are increasingly investigated for their potential to mitigate OA progression.
  • Evaluating nutraceutical efficacy requires robust preclinical models.

Purpose of the Study:

  • To review animal models used in studying nutraceutical effects on osteoarthritis.
  • To provide guidance on selecting appropriate OA models for nutraceutical research.
  • To highlight the diversity of available animal models for OA research.

Main Methods:

  • Systematic review of existing literature on animal models for OA and nutraceutical intervention.
  • Analysis of different types of OA induction methods in animal studies.
  • Categorization of animal models based on relevance to OA pathophysiology.

Main Results:

  • A wide array of animal models are currently employed to study OA.
  • Each model possesses unique advantages and limitations for evaluating nutraceuticals.
  • Model selection significantly impacts the interpretation of nutraceutical efficacy.

Conclusions:

  • Standardized guidelines for selecting animal models in nutraceutical OA research are needed.
  • Appropriate model selection is crucial for validating the therapeutic potential of nutraceuticals.
  • Further research should focus on aligning specific OA models with desired nutraceutical outcomes.